Showing results (1811-1820 of 2,014) with videos related to

Sort By:
Pageof 202
Chemmedchem|December 25, 2014
Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybridsMohamed Benchekroun, Manuela Bartolini, Javier Egea, et al.
European Journal of Medicinal Chemistry|February 17, 2019
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenaseEhab D AlFadly, Perihan A Elzahhar, Anna Tramarin, et al.
Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
The Lancet. Oncology|September 16, 2018
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma GroupGiovanni Grignani, Lorenzo D'Ambrosio, Ymera Pignochino, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 30, 2013
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settingsMonica Loi, Daniela Di Paolo, Marco Soster, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 8, 2026
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in ItalyValentina Perrone, Gregorio Barilà, Luca Franceschini, et al.
Journal of Neurointerventional Surgery|May 15, 2023
Antithrombotic regimen in emergent carotid stenting for acute ischemic stroke due to tandem occlusion: a meta-analysis of aggregate dataFrancesco Diana, Mohamad Abdalkader, Daniel Behme, et al.
Brain : a Journal of Neurology|February 11, 2022
Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's diseaseLeticia Peris, Julie Parato, Xiaoyi Qu, et al.
Biomaterials|August 16, 2015
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusionIrene Cossu, Gianluca Bottoni, Monica Loi, et al.
Iscience|November 18, 2020
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic LethalityPaola Sanese, Candida Fasano, Giacomo Buscemi, et al.
Pageof 202